DARZALEX® (daratumumab) based regimens significantly improve clinical[...]
CARVYKTI® (ciltacabtagene autoleucel) significantly improved[...]
Late breaking results from PALOMA 2 study of subcutaneous amivantamab[...]
05/22/2024 | Press release | Distributed by Public on 05/22/2024 03:04
Please select the service you want to use:
Smartlinks | Ministry of Foreign Affairs of the Kingdom of Norway | Government of Norway | News | International News | Politics and Policy | Policy and Regulation | Government | National Government | Executive Government | Government Departments | International Policy | Financial Statement | Departments of Foreign Affairs
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact